Search Results 1071-1080 of 11991 for lisinopril

  1. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  2. Publications - Melissa A. Lyle, M.D. - Mayo Clinic

    Lateef A, Seby R, Ma Y, Malik A, Lyle M, Munoz FD, Gharacholou SM. Electrocardiographic parameters and outcomes in patients with cardiac amyloidosis and ...

  3. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer - Mayo Clinic

    About this study. This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, ...

  4. Primary biliary cholangitis (PBC)

    Mayo Clinic has been conducting research on primary biliary cholangitis for more than 40 years, and many treatments for the disease have been studied at ...

  5. Esomeprazole (oral route) - Side effects & dosage - Mayo Clinic

    It is used to treat duodenal and gastric ulcers, erosive esophagitis, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome, a condition ...

  6. Chronic kidney disease - Doctors and departments - Mayo Clinic

    Learn about kidney failure symptoms, tests, diagnosis and treatment options, including medicine, dialysis and kidney transplant.

  7. Publications - Sabrina D. Phillips, M.D. - Mayo Clinic

    Chiriac A, Cheema KP, Giardi D, Espinosa SM, Fitzgerald P, Perez-Downes JC, Umadat G, Hodge DO, Phillips SD, Madhavan M, Asirvatham SJ, McLeod CJ. Atrial ...

  8. Cardiovascular Medicine - Clinical trials

    The purpose of this study is to develop an in vitro cardiac organoid model representative of hypertrophic cardiomyopathy from myectomy-derived myocardial ...

  9. Phase 2/3 Open-Label Trial Of Sibeprenlimab In The Treatment Of Immunoglobulin A Nephropathy - Mayo Clinic

    This is a phase 2/3 open-label trial to evaluate the long-term safety, tolerability, and efficacy of sibeprenlimab administered subcutaneously (SC) in subjects ...

  10. A Study Of TRX319 In Subjects With Primary Or Secondary Progressive Multiple Sclerosis - Mayo Clinic

    Patients with progressive forms of multiple sclerosis (MS) have limited. therapeutic options and require new, effective treatments. Ocrelizumab, an.